NCT05266521

Brief Summary

The zLOCK Facet Stabilization System is a fixation device intended to provide posterior stability in the lumbar spine fusion procedure. The system can be placed either as an adjunct to an inter-vertebral anterior cage or as stand-alone with/ without additional decompression of the dural sac or nerve roots as appropriate for the specific patient and surgeon's discretion. The zLOCK implant is placed inside the facet to stabilize the motion and enhance the bony fusion of the joint. The zLOCK Facet Stabilization System is intended for single-level stabilization of a spinal motion segment in order to promote bony fusion of the joint. The zLOCK system is indicated for use from L1-L2 to L5-S1 joints. The zLOCK implant is inserted into the facet joint space while adapting to the joint's changing geometry. Stabilization is achieved by a firm grip of each joint bone and resisting any relative motion. The zLOCK implant is placed percutaneously and requires only one incision per side, thereby reducing the invasiveness procedure duration and shortening the recovery period. This pivotal study was designed in order to assess the safety and effectiveness of the zLOCK system.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable low-back-pain

Timeline
Completed

Started Nov 2021

Longer than P75 for not_applicable low-back-pain

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 13, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

February 7, 2024

Status Verified

February 1, 2024

Enrollment Period

3.2 years

First QC Date

February 13, 2022

Last Update Submit

February 6, 2024

Conditions

Keywords

StabilizationFacet arthritisSpondylolisthesisStenosis

Outcome Measures

Primary Outcomes (1)

  • Incidence of Treatment-Emergent Adverse Events as assessed by paucity of device related reoperation

    The safety of the zLOCK Facet Implant System will be established based on the paucity of device-related reoperations.

    3 months

Secondary Outcomes (1)

  • Change in pain level measured by Visual Analog Score for pain

    1 year

Study Arms (1)

zLock Facet Locking Implant System

EXPERIMENTAL

Device: zLOCK Facet Stabilization System zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains

Device: zLOCK Facet Stabilization System

Interventions

zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains

zLock Facet Locking Implant System

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is scheduled for spine surgery with at least one of the following:
  • Degenerative Spondylolisthesis grade 1;
  • Mild to Moderate stenosis;
  • Degeneration of the facets.
  • When used stand-alone disc height should be maximum 50% of the adjacent disc height.
  • \< Age \<75
  • Weight \< 100Kg
  • Signed informed consent form
  • At least 3 months of unsuccessful conventional treatments

You may not qualify if:

  • Fusion procedure performed or required in more than one motion segment.
  • Acute or chronic spinal infections.
  • Osteoporosis when used in adjunct to an anterior interbody cage (DEXA \< -2.5).
  • Absence of posterior spinal elements including the pedicle, pars interarticularis, facet joints, spinous process and the majority of the lamina which make it unstable or not possible to place.
  • Any entity or conditions that totally preclude the possibility of fusion, i.e. cancer or kidney dialysis.
  • Obesity (BMI ≥30)
  • Unilateral application of device, except in combination with anterior interbody cages.
  • Known sensitivity to Titanium.
  • Alcoholism, or drug abuse
  • Subject with a cardiac pacemaker or other implanted electro medical device
  • Women who are either pregnant or nursing at the time of screening (to be verified by test in case of woman of child-bearing potential that do not practice medically acceptable methods of contraception)
  • Concurrent participation in another clinical trial using any investigational drug or device.
  • Mental disorders.
  • Tumor
  • Fracture or other instabilities of the posterior elements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

MedizinischenFakultät der Universität Rostock

Rostock, 18055, Germany

RECRUITING

AOU Policlinico "Paolo Giaccone"

Palermo, Italy

RECRUITING

MeSH Terms

Conditions

Low Back PainSpondylolisthesisConstriction, Pathologic

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpondylolysisSpondylosisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesPathological Conditions, Anatomical

Study Officials

  • Hanna Levy, Dr.

    ZygoFix

    STUDY DIRECTOR

Central Study Contacts

Hanna Levy, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2022

First Posted

March 4, 2022

Study Start

November 7, 2021

Primary Completion

January 30, 2025

Study Completion

September 30, 2025

Last Updated

February 7, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations